Last reviewed · How we verify

NCT01865357: SCI-COG

Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRI

Completed NA Last updated 3 October 2018
What this trial tests

NA trial testing Brain MRI - Clinical and cognitive evaluation in Clinically Isolated Demyelinating Syndromes in 117 participants. Completed in 1 December 2016.

Timeline
24 August 2012
Primary endpoint
1 December 2016
1 December 2016

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment117
Start date24 August 2012
Primary completion1 December 2016
Estimated completion1 December 2016
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Clinically Isolated Demyelinating Syndromes or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinically isolated demyelinating syndromes (CIS) can evolve into multiple sclerosis (MS). Cognitive deficiencies could occur at this early stage and concern mainly information processing speed (IPS) and their mechanisms are not fully understood. Diffusion Tensor Imaging (DTI) can help in the understanding of these mechanisms.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Regional hippocampal vulnerability in early multiple sclerosis: Dynamic pathological spreading from dentate gyrus to CA1.
    Planche V, Koubiyr I, Romero JE, Manjon JV, et al · · 2018 · cited 46× · PMID 29331060 · DOI 10.1002/hbm.23970
  2. Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
    Moroso A, Ruet A, Lamargue-Hamel D, Munsch F, et al · · 2017 · cited 44× · PMID 27789541 · DOI 10.1136/jnnp-2016-313867
  3. Pattern separation performance is decreased in patients with early multiple sclerosis.
    Planche V, Ruet A, Charré-Morin J, Deloire M, et al · · 2017 · cited 16× · PMID 28828205 · DOI 10.1002/brb3.739
  4. Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome.
    Koubiyr I, Deloire M, Coupé P, Dulau C, et al · · 2018 · cited 10× · PMID 30364223 · DOI 10.3389/fneur.2018.00824
  5. Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment.
    Moroso A, Ruet A, Lamargue-Hamel D, Munsch F, et al · · 2017 · cited 8× · PMID 28792528 · DOI 10.1371/journal.pone.0182479
  6. Insights on the Relationship Between Hippocampal Connectivity and Memory Performances at the Early Stage of Multiple Sclerosis.
    Boscheron J, Ruet A, Deloire M, Charré-Morin J, et al · · 2021 · cited 6× · PMID 34093415 · DOI 10.3389/fneur.2021.667531

Verify or expand the search:

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01865357.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing